Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 6/20 | 0.50 |
| ▸ | CALCR | P30988 | 4/20 | 0.49 |
| ▸ | NTSR1 | P30989 | 3/20 | 0.48 |
| ▸ | NPY1R | P25929 | 1/20 | 0.46 |
| ▸ | NPY2R | P49146 | 1/20 | 0.46 |
| ▸ | NPY4R | P50391 | 1/20 | 0.46 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.46 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.46 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.46 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29826838 | 0.93 | OPRD1 (0.59) | OPRD1CALCRNTSR1 | |
| SCHEMBL29509550 | 0.93 | OPRD1 (0.59) | OPRD1CALCRNTSR1 | |
| SCHEMBL31462127 | 0.87 | EP300 (0.48) | CALCRNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31462047 | 0.87 | CALCR (0.49) | CALCRNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31462080 | 0.87 | CALCR (0.48) | CALCRNPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31336659 | 0.86 | NTSR1 (0.50) | OPRD1NTSR1NPY1RNPY2RNPY4R | |
| SCHEMBL31174232 | 0.86 | NTSR1 (0.51) | OPRD1CALCRNTSR1NTSR2SORT1 | |
| SCHEMBL31461927 | 0.85 | CALCRL (0.46) | OPRD1CALCRNTSR1 | |
| SCHEMBL30457013 | 0.85 | OPRD1 (0.63) | OPRD1NTSR1NTSR2SORT1 | |
| SCHEMBL30497011 | 0.85 | OPRD1 (0.67) | OPRD1CALCRNTSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3864028-B1 | OLIGONUCLEOTIDE-BASED TUNING OF PORE-FORMING PEPTIDES FOR INCREASING PORE SIZE, MEMBRANE AFFINITY, STABILITY, AND ANTIMICROBIAL ACTIVITY | ADOLPHE MERKLE INSTITUTE UNIV OF FRIBOURG (CH) | 2026-03-25 | — | — | EP | claimed |
| US-12281178-B2 | Tuning of pore-forming peptides for increasing pore size, membrane affinity, stability, and antimicrobial activity | ADOLPHE MERKLE INSTITUTE, UNIVERSITY OF FRIBOURG (CH) | 2025-04-22 | — | — | US | claimed |
| CN-113166209-B | Oligonucleotide-based modulation of pore-forming peptides to increase pore size, membrane affinity, stability and antimicrobial activity | 弗里堡大学阿道夫梅克尔研究所 | 2025-01-07 | — | — | CN | claimed |
| EP-3864028-B1 | OLIGONUCLEOTIDE-BASED TUNING OF PORE-FORMING PEPTIDES FOR INCREASING PORE SIZE, MEMBRANE AFFINITY, STABILITY, AND ANTIMICROBIAL ACTIVITY | ADOLPHE MERKLE INSTITUTE UNIV OF FRIBOURG (CH) | 2026-03-25 | — | — | EP | disclosed |
| EP-3574909-B1 | POLYELECTROLYTE MULTILAYER COMPRISING SILVER FOR WOUND HEALING | IMBED BIOSCIENCES INC (US) | 2026-03-04 | — | — | EP | disclosed |
| US-12564617-B2 | Methods for modulating macrophage activity | Riptide Bioscience, Inc. (US) | 2026-03-03 | — | — | US | disclosed |
| US-20260000805-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | IMBED BIOSCIENCES INC (US) | 2026-01-01 | — | — | US | disclosed |
| US-12409247-B2 | Methods and compositions for wound healing | IMBED BIOSCIENCES INC. (US) | 2025-09-09 | — | — | US | disclosed |
| US-12359240-B2 | Membrane protease-based methods for detection of bacteria | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2025-07-15 | — | — | US | disclosed |
| US-12281178-B2 | Tuning of pore-forming peptides for increasing pore size, membrane affinity, stability, and antimicrobial activity | ADOLPHE MERKLE INSTITUTE, UNIVERSITY OF FRIBOURG (CH) | 2025-04-22 | — | — | US | disclosed |
| CN-113166209-B | Oligonucleotide-based modulation of pore-forming peptides to increase pore size, membrane affinity, stability and antimicrobial activity | 弗里堡大学阿道夫梅克尔研究所 | 2025-01-07 | — | — | CN | disclosed |
| US-20240009342-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | IMBED BIOSCIENCES INC. | 2024-01-11 | — | — | US | disclosed |
| EP-4289910-A2 | METHODS AND COMPOSITIONS FOR WOUND HEALING | Imbed Biosciences, Inc. (US) | 2023-12-13 | — | — | EP | disclosed |
| EP-3490622-B1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | IMBED BIOSCIENCES INC (US) | 2023-09-06 | — | — | EP | disclosed |
| WO-2023141679-A1 | DIMERS AND USES THEREFOR | THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH (AU) | 2023-08-03 | — | — | WO | disclosed |
| US-11554194-B2 | Methods and compositions for wound healing | IMBED BIOSCIENCES INC. (US) | 2023-01-17 | — | — | US | disclosed |
| US-20220205015-A1 | MEMBRANE PROTEASE-BASED METHODS FOR DETECTION OF BACTERIA | NORTHWESTERN UNIVERSITY | 2022-06-30 | — | — | US | disclosed |
| EP-3995158-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | Imbed Biosciences, Inc. (US) | 2022-05-11 | — | — | EP | disclosed |
| US-20220062373-A1 | Methods for Modulating Macrophage Activity | Riptide Bioscience, Inc. | 2022-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12564617-B2 | Methods for modulating macrophage activity | MSR1, CSF1R, CD209 | OPRD1 585/4885CALCR 355/4885NTSR1 237/4885 |
| US-20260000805-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | PCNA, ARG1, PLOD3 | OPRD1 2565/4885CALCR 2540/4885NTSR1 3816/4885 |
| US-20220062373-A1 | Methods for Modulating Macrophage Activity | CD209, CD68, CD14 | OPRD1 1827/4885CALCR 272/4885NTSR1 275/4885 |
| US-20220205015-A1 | MEMBRANE PROTEASE-BASED METHODS FOR DETECTION OF BACTERIA | PDXK, PPOX, PCNP | OPRD1 1711/4885CALCR 3664/4885NTSR1 1738/4885 |
| US-12359240-B2 | Membrane protease-based methods for detection of bacteria | PDXK, PPOX, PCNP | OPRD1 1711/4885CALCR 3664/4885NTSR1 1738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.